這個藥物其實之前介紹過：
[US pharmacist]New Drug Review 2012 新藥回顧
結構：
不過這邊把一些收集到的機轉圖給各位參考：
機轉：
Abiraterone acetate is metabolized to abiraterone, an androgen biosynthesis inhibitor of CYP17 which decreases androgen levels and deprives androgen-sensitive prostatic carcinomas. It accomplishes this by interfering with the CYP17-catalyzed reactions involved in the production of dehydroepiandrosterone (DHEA) and androstenedione. Inhibition of CYP17 can result in increased mineralocorticoid production by the adrenals
文章標籤
全站熱搜
留言列表
醫藥類 (14)
